Biocept Inc (NASDAQ:BIOC)

0.89
Delayed Data
As of Oct 04
 0.00 / 0.00%
Today’s Change
0.72
Today|||52-Week Range
4.40
-75.41%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$15.6M

Company Description

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

Contact Information

Biocept, Inc.
9955 Mesa Rim Road
San Diego California 92121
P:(858) 320-8200
Investor Relations:

Employees

Shareholders

Other institutional6.13%
Mutual fund holders5.11%
Individual stakeholders0.03%

Top Executives

Samuel D. RiccitelliChairman, President & Chief Executive Officer
Philippe MarchandChief Operating Officer
Antonino MoralesChief Financial Officer, Secretary & Director
Michael C. DuganChief Medical Officer & Medical Director
Darrell TaylorSVP, Chief Legal & Compliance Officer